Davies et al. [1] screened the coding sequence and intron–exon junctions of BRAF for mutations in more than 900 human cancer cell lines and primary tumours, and found somatic missense mutations in 66% of malignant melanomas and in a smaller proportion of many other human cancers. This evidence concerns the gene BRAF and cancer.